Akeso Inc. announced that eClinical Medicine, a sub-journal of The Lancet, recently published the results of a phase II clinical trial of ivonescimab combined with chemotherapy for the treatment of non-small cell lung cancer.
Akeso Inc. announced that eClinical Medicine, a sub-journal of The Lancet, recently published the results of a phase II clinical trial of ivonescimab combined with chemotherapy for the treatment of non-small cell lung cancer.